Objective: Motivated by the high-throughput genotyping technology, our goal is to experimentally compare the power and accuracy of case-control and family trio-based approaches for haplotype-based, large-scale association gene mapping.
INTRODUCTION
Gene mapping efforts have been criticized for their modest success at finding-and replicating findings of-disease susceptibility genes. While linkage methods are popular in trying to elucidate the genetic basis of complex traits, they have inherent limitations in detecting genes of modest-to-moderate effect. [1] Association analysis using haplotypes is a good alternative: it has better resolution, and thus also the capability to better utilize high density genotype data produced by high-throughput genotyping techniques. Further gene mapping studies that only use triad or case-control data from epidemiological cohorts greatly reduce the amount of effort required to obtain the DNA samples, compared to linkage analyses based on large families.
Haplotype analyses are of increasing interest to a wide variety of investigators, and thus raise the issue of the most relevant study settings-including ascertainment scenarios and computational analysis methods-to be used in practice. In addition, understanding differences between family-based and population-based methods is useful for those planning new genetic studies. The goal of our simulation study is to shed light on these issues.
We present the results of a simulation study where we compared experimentally two strategies for study design and haplotyping in association analysis: (1) a trio-based setting, where trios are ascertained using affected children as probands, and the nontransmitted haplotypes of the parents are used as controls or additional cases, depending on the phenotype of the parent; and (2) a case-control study design, where cases are ascertained as above but independent healthy control individuals are sampled from the population, and where the haplotypes are estimated for all individuals with a populationbased statistical method. The methods we used are computationally efficient and they are therefore a valid alternative for the analysis of large datasets. The simulated population was an exponentially and rapidly growing founder population, similar to ones successfully used in gene mapping studies. [2] According to our results, population-based reconstruction of haplotypes in case-control data sets combined with association analysis can clearly outperform the trio-based approach, even if the haplotypes from all trios could be solved unambiguously. We experimentally analyzed the effects of adjusting sample sizes for equal genotyping costs, of haplotyping, and of the sample ascertainment. An unexpected result was obtained about the effect of population-based haplotypes: they turned out to be very powerful in association studies, and in our experiments they were virtually equally good to the true (unknown) haplotypes. The results were confirmed with a real data set used for localization of an asthma gene. [3] Based on these results, we claim that case-control study designs may serve in general as powerful starting points for genetic association analyses, without an obligatory need of genotyping the families. Further, we suggest that relatively simple but efficient haplotype association analysis can be sufficiently powerful in high-throughput analysis.
METHODS
We used simulated datasets to carry out the study, since they allow power analysis using a large number of replicate data sets with controlled values of parameters. Different sampling and haplotyping methods and eventually a haplotype association mapping algorithm were then applied to each of these replicates in turn. The power to detect the disease susceptibility gene was then analyzed, as well as the mapping accuracy. By controlling each of the parameters separately we were able to analyze their effects in isolation. A recent asthma dataset was used to confirm the results with real data.
The compared settings differed in three major aspects (Table 1): 1. Sample ascertainment: In all our sampling designs, an affected child is used as a proband. In the trio design, the non-transmitted (pseudo) haplotypes of parents are used as controls or additional cases, according to the phenotype of the parent. In the case-control design, healthy individuals are sampled from the population; in For association analysis, we used haplotype association with all haplotypes between 1 and 10 markers of length. This simplicity was a deliberate choice: the method easily scales up to very large data sets. While it is simple, it is also quite powerful, as will be shown by comparisons to EATDT [4] . A comparison of different association analysis methods is outside the scope of this paper; we aim specifically at comparing study designs and the related haplotyping approaches.
Simulation
We used a two-phase simulation procedure to mimic a true founder population. In the first phase the founder haplotypes are simulated using a coalescent model with recombination and infinite sites mutation model, to produce a realistic polymorphism on 16 April 2008 jmg.bmj.com Downloaded from structure and realistic allele frequency distributions for the founder chromosomes. In the second phase, the final population is simulated using forward-in-time simulation to obtain a larger population with a realistic recombination history. (See the appendix for more details.)
The population model we used is an exponentially and rapidly growing founder population, which starts with 100 founder individuals randomly chosen from the coalescence simulation. The final size, 100,000 individuals, is reached in 15 generations. This approximately corresponds to a recently founded subpopulation living in isolation, such as Kainuu region in North-Eastern Finland. [2] The marker map in our study consists of SNPs separated by approximately 33 kb from each other, corresponding to the average density of a genome-wide 100k microarray SNP chip. We simulated 451 markers, i.e., a stretch of 15,000 kb (15 cM). The SNPs were chosen to have minor allele frequency at least 0.05. As a result of picking markers based on these two criteria, the average minor allele frequency was 0.21 and the average distance between markers was 33 kb (with 2.63 kb standard deviation on average).
Three disease models were designed to resemble interesting and challenging cases ( Table 2 ). "Common" is a common disease variant, with susceptibility allele frequency of 20% in the population and low penetrance (20%), created to correspond to a typical common complex disease, such as asthma or diabetes in human populations. "Rare" is a model with low susceptibility allele frequency (1%) and low prevalence (5%) in the population, and with 40% penetrance (in accordance to the rare variant, rare disease hypothesis). This corresponds to a typical inherited disease studied since the late 90's. Finally, a disease model called "Intermediate" with susceptibility allele frequency in between those of the rare and common was created (10%), with intermediate penetrance (30%). Other disease model parameters were set so that the proportions of phenocopies were 28% (common model), 58% (intermediate) or 78% (rare). All these models result in relatively difficult mapping problems where differences between methods and approaches can be more easily observed than with easier models. After diagnosing the final simulated generation using the disease model, we ascertained samples of cases, random individuals, and healthy controls (corresponding to the columns of Table 1 ). Siblings were not allowed in samples. In order to minimize the random effects caused by random sampling of individuals, the overlap of the samples for different strategies was maximized for a given replicate: the set of cases was identical in all the strategies, and the healthy individuals of the case-random design were a subset of the controls of the case-control design. This held for both sample sizes. Further, the smaller sample was a subset of the larger one. Since we report results over 100 independent simulations in each setting, we believe the random effects are well controlled. We do not handle the issue of population stratification in this report. The trio design is generally robust to stratification effects; in case-control studies false positives resulting from population substructure can be reduced by genomic control (see, e.g., Devlin et al. [5] ).
Haplotyping
Trio-based inference of haplotypes was done simply by deducing the phase of each marker from the genotypes of the child and the parents. If all members of the trio were heterozygous at a marker, the respective alleles of the child and the pseudo-haplotype were denoted unknown in the haplotypes. This caused a part of the data to be missing. More complex methods for haplotype inference would estimate the phases of these markers and eventually improve the quality of the haplotypes. We also used the best possible case, true haplotypes, to approximate an upper limit for (family-based) haplotyping.
For population-based statistical reconstruction of haplotypes we used the HaploRec algorithm. [6] The method works by fitting a variable-order Markov chain model of haplotypes to the observed genotype data (see the appendix for more details). Unlike most other methods for population-based haplotyping, HaploRec allows recombinations in the marker map and does that without assuming a specific haplotype block structure. Since it is also computationally efficient, we chose it for our study involving a large number of individuals and markers.
Association analysis methods
Allelic association was estimated by predicting the disease susceptibility locus to be at the marker that has the highest value for the χ 2 test statistic. For haplotype association, each haplotype of length 1 to 10 markers was evaluated with the χ 2 test. Then, the disease susceptibility gene was predicted to reside in the middle point of the best haplotype. In case of a draw, one of the best markers or haplotypes was chosen at random.
For each data set, the p-value of the best allele or haplotype was computed by a permutation test: the disease-association statuses of the original haplotypes were randomly shuffled 9,000 times, the value of each permutation was used as the test statistic. This procedure takes into account the multiple testing of haplotypes and produces a corrected p-value.
We estimated the statistical power to detect the disease susceptibility gene at significance level α = 0.05. Because the simulated chromosomes were only 15 cM longapproximately 1 / 187 of the human genome-we adjusted the p-values for genome-wide analysis by Šidák-correction, essentially assuming that the genome consists of 187 independent 15 cM blocks: the genome-wide p-value p * was estimated by p * = 1 -(1 -p) 187 , where p is the p-value obtained for the simulated 15 cM region using permutation tests.
In addition to the statistical power to detect the disease susceptibility gene, the association analysis methods described above give a point estimate for the locus as a result, and the results over 100 simulation replicates give a sample of prediction errors. The accuracy of association analysis can be then visualized as a cumulative distribution function of (absolute) prediction error.
Throughout the results, the maximum prediction error shown will be 1,000 kb (1 cM in the simulated data) as prediction errors over 1 cM to either side of the true disease susceptibility gene location are not particularly interesting for fine mapping. With the population and disease models used, the methods are reasonably accurate, so that most of the interesting differences lie within this range. In addition to the experimental error curves, the prediction error of uniform random guesses (without any data) is given in all figures for reference. With our disease models, detecting the presence of a gene is more difficult than locating it, and correspondingly the powers are much less than one. However, this design is intended to bring out differences between the methods.
RESULTS
A direct comparison of the case-control and trio designs, under the assumption of equal genotyping costs, shows that the case-control design is more accurate for association analysis by a large margin across the three different disease models (Fig. 1 .A, common and rare models; Fig. 1 .B, intermediate model). Even in the best possible case (i.e., with true haplotypes) the accuracy of the trio design was clearly inferior to the case-control designs. The differences in the statistical power to detect the gene are even more striking (Table 3) To validate the use of the relatively simple haplotype association mapping method in this study, we compared the results to those obtained by allelic association and by the recently introduced EATDT method (Exhaustive Allelic Transmission Disequilibrium Test, applicable to trio-based data only). [4] The haplotype association method used in this study actually outperforms both allelic association and EATDT ( Fig. 1 .C, intermediate model; Table 3 , last two lines), indicating that it is powerful and accurate, and therefore
suitable for measuring the differences between different study design and haplotyping approaches.
We next perform a detailed experimental analysis of the differences between the casecontrol and trio-based approaches. In particular, we isolate the effects caused by sample size, sample ascertainment, and haplotyping method, and study each of them separately. For illustration, we only show prediction accuracy curves for the intermediate disease model, the most difficult one; the power and prediction results for all three disease models are summarized in Table 3 .
Sample size
The most obvious cause for the performance differences above is the sample size: with equal genotyping costs, the effective sample size in the trio-based approach is only two thirds of that in the population-based approach. However, the difference in sample size only explains a part of the difference (Fig. 1 .D, intermediate model; Table 3 ).
Sample ascertainment
The two sample ascertainment methods are quite different. In the trio-based approach the non-transmitted chromosomes of the parents are used as additional data: as a pseudocontrol if the parent is healthy, or as a pseudo-case if the parent is diseased. This procedure often results in somewhat unbalanced numbers of cases and controls, but this does not seem to have much effect on the mapping accuracy (results not shown).
To test the effect of sample ascertainment, we conducted experiments where the sample size and haplotyping method were fixed, and only the origin of controls varied. In particular, population-based controls were in some experiments haplotyped using their parents to form trios. According to the results, there is virtually no difference in the prediction accuracies between the two major sample ascertainment methods ( Fig. 1.E,  intermediate model) . In terms of the power to detect a gene, on the other hand, population-based controls tend to be more powerful than trio-based data (Table 3) .
Sampling random individuals instead of healthy ones has a clear negative effect. For the most difficult disease model, the intermediate one, the effect is comparable to the effect of sample size. For easier models, the effect is smaller. A trio-based strategy where all non-transmitted haplotypes are labeled as controls yields similar results compared to sampling random individuals (results not shown).
Haplotyping method
The final aspect in which the case-control and trio-based approaches differ is the haplotyping method. Population-based reconstruction is based on estimated phases which can contain errors, especially with the long maps used in this study (451 markers, 15 cM). The simple trio-based approach we used, on the other hand, cannot always resolve the phase of a marker, in which case we have marked the alleles as unknown. The true Controlled experiments, where other factors (in particular, sample size and sample ascertainment) are constant, show that the mapping results obtained with populationbased haplotyping are virtually identical to those obtained with the true haplotypes across all tests (Fig. 1.F, Table 3 ). In other words, the (few) phasing errors did not affect mapping power or accuracy.
The simple trio-based haplotyping, in turn, is clearly inferior. This is explained by the amount of missing data, since all inferred phases have to be correct. On average, triobased haplotyping resulted in 5.4% missing alleles in our simulated data sets. In the best case, a sophisticated trio-based haplotyping method would give mapping accuracy equal to the true and the population estimated haplotypes (Fig. 1.D) . However, the power of the trio design to detect a gene remains inferior to the case-control design even in this case (Table 3) .
Example: Asthma data
We demonstrate the power of the case-control design and population-based haplotyping on real asthma data, consisting of 194 small families. To mimic the case-control study design, we used families with an affected and a healthy parent, constituting an effectively independent case-control pair. For the trio-based approaches, we also randomly sampled one child in each of the families. We sampled at most one such trio per pedigree, giving 93 trios from the available 194 pedigrees.
All markers with at least 20% of genotypes missing were rejected. The remaining marker map consisted of 73 microsatellite and 15 SNP markers. We haplotyped the case-control data set of affected and healthy parents using HaploRec. For comparison, we inferred the haplotypes of a random subsample of 62 trios (two thirds of 93) utilizing the genotypes of the children. Additionally, we subsampled the haplotypes of the parents in the 62 trios from the set of 93 case-control pairs haplotyped using HaploRec. This data set represents our best estimate of the haplotypes in the trios.
With the case-control sample there is a strong association peak within the correct 133-kb region, but also a false positive about 500 kb to the right (Fig. 2) . In contrast, the triobased setting does not show any associations within the correct region, but two false positives instead. Increasing the sample size to include all 93 trios did not produce any different results (data not shown). This is a strong indication of the potential of the casecontrol approach to association mapping.
DISCUSSION
We reported on simulation experiments where we compared sample ascertainment strategies and related haplotyping approaches in association mapping studies. We considered two main alternatives: ascertainment of family trios with an affected child, from which it is easy to infer the haplotypes partially, and ascertainment of a case-control sample of unrelated individuals, for which the haplotypes were estimated statistically. We conducted the mapping step using haplotype association analysis, a simple but powerful and efficient method. Case-control samples were haplotyped with HaploRec. [6] Both haplotype association and HaploRec scale up to large amounts of markers and individuals and are suitable for high-throughput association studies. Finally, we isolated and experimentally analyzed the effects of three separate factors: sample size, sample ascertainment method, and accuracy of haplotyping.
For an equal number of genotyped individuals, the effective sample size in the trio-based approach is only two thirds of that of the case-control design. According to our experiments, this difference has a major effect on the mapping power and accuracy, as expected.
In order to maximize the genetic effect in the sample, the controls should be ascertained from unaffected individuals to minimize the frequency of disease susceptibility allele. In a population-based study, it can be possible to ascertain healthy controls for this purpose. Alternatively, random population controls are often used since their ascertainment is easier, especially if they are stratified to match the cases. For rare diseases the difference between healthy and random controls is marginal.
We ascertained the cases in a standard manner, using an affected child as a proband. If all affected individuals are equally likely to be chosen as probands, then families with several affected children will be overrepresented in the sample (known as classical ascertainment bias; see, e.g., Fisher [7] or Cannings [8] ). For association analysis, this bias increases the power as then the expected frequency of the disease susceptibility gene is further elevated in the cases.
According to our results, the case-control setting is more powerful than the trio-based design, but they are roughly equally accurate. The case-random design was clearly inferior, but this depends on the disease model, in particular the susceptibility allele frequency. Trios have the benefit that they produce controls that are well paired with cases for population substructure and other factors that are not uniform over the population. Ascertainment of matching controls from the population is more difficult, but genomic control can be used to correct for stratification. [5] We did not simulate any population substructure effects.
In our experiments, haplotypes inferred with a population-based statistical method were equally powerful to using the true haplotypes. This is in contrast to the result of Morris el al., who concluded that statistically inferred haplotypes are inferior to the true haplotypes, and genotype-based approaches should be preferred instead. [9] There are several differences between our studies that can partially explain the results. First, the results of Morris et al. are based on a shorter map (950 kb interval and 20 SNPs vs. 15,000 kb and 451 SNPs in our study). Second, Morris et al. used their own COLDMAP software for mapping. (We could not evaluate the effect of this choice since, according to Morris et al. themselves, COLDMAP is not feasible for data sets of the size of our study. [9] ) Third, they used SNPHAP (by David Clayton) to estimate haplotypes. SNPHAP is not well suited for long maps with recombinations, and is likely to be a suboptimal choice here (we could not evaluate it in our study since it often stopped without haplotyping all individuals). As a fourth reason, different simulation techniques were applied.
The effect of haplotyping accuracy on fine mapping is greatest near the disease susceptibility locus in the haplotypes carrying the disease susceptibility allele. Since this is exactly where linkage disequilibrium is increased in the cases, this area is likely to be best haplotyped by methods that give emphasis on local structure, such as HaploRec. It was found to have excellent switch accuracy, 99.6% and 99.3% on average for sample sizes 500 and 334, respectively. (Switch accuracy is defined as the fraction of neighboring phases (between each pair of consecutive heterozygous markers) reconstructed correctly.)
With the trio-based haplotype inference the only source of uncertainty are similar heterozygotes, for which we marked the alleles as unknown in our simple method. This resulted in a poorer association mapping performance compared to the population-based estimates. Based on this result, an obvious recommendation is to use population-based techniques to augment trio-based inference when trios are available, to avoid missing alleles. However, our experiments with the true haplotypes suggest that even the best possible haplotyping method would give the same mapping accuracy than the populationbased haplotyping, and the power to detect the gene would remain inferior compared to the case-control design due to the smaller effective sample size.
Despite some contrasts with the conclusions of Morris et al. [9] , we do agree with many of their points. In particular, mapping results based on inferred haplotypes are likely to be optimistic in terms of confidence or credibility intervals, due to exaggeration of linkage disequilibrium.
In further research, it is important to test the utility of the case-control study design in more real life experiments, to verify that it does not suffer from unexpected effects from genotyping errors, missing data, or varying disease models. The effect of more elaborate association methods (e.g. those proposed by Purcell et al. [10] ) to the power and mapping accuracy should be investigated, although our comparisons to EATDT suggest that the simple haplotype association with a population-based haplotyping is a powerful alternative for association analysis.
Conclusions
For future high-throughput association mapping studies, case-control design combined with efficient population-based haplotyping method can be more powerful alternative than the trio design. To enrich the specific disease susceptibility genes in the cases, the cases should rather be familial than sporadic. Naturally, the opposite holds for the controls: it is useful if the presence of the specific disease or trait in question can be reliably excluded. The down-side of using population controls is that it may prove difficult to find controls matched for ethnic origin in studies of stratified or mixed populations; genomic control alleviates some of the issues.
According to our results, data from existing epidemiological research projects, consisting of cases only, or case-control pairs, can be easily and effectively utilized in large scale haplotype-based association analysis. This opens great opportunities for utilizing the vast blood stain or biopsy collections maintained in many university hospitals and national health institutes.
DATA ACCESS
HaploRec software for population-based reconstruction of haplotypes and the simulated datasets are available on the WWW at http://www.cs.helsinki.fi/group/genetics/. Population Biology 1999;55:248-259. 
APPENDIX: TWO-PHASE SIMULATION PROCEDURE
We used a two-phase procedure for the simulation of relatively young, isolated founder populations. In the first phase the founder chromosomes were simulated using a coalescent model with recombination and the infinite sites mutation model. [11] We used a coalescent simulation procedure based on the spatial algorithm of Wiuf and Hein.
[12] The spatial algorithm produces a graph similar to the ancestral recombination graph of Griffiths and Marjoram.
[13] The algorithm first generates a tree genealogy for one end of the sequence using the standard coalescent model, and then iteratively proceeds over the sequence until it is covered in its entirety. In each iteration, the distance to the next crossover in any of the lineages in the current graph is first drawn from an exponential distribution. Then a new recombination node is generated to a randomly chosen point in the graph, splitting the lineage at the chosen point. The new upgoing lineage is merged with a randomly chosen lineage.
In our implementation, when updating the graph, we ignore the lineages of the graph that are no longer part of the local genealogical tree. This way the graph is a tree at all times, and, consequently, the algorithm simulates long sequences much faster. Although our model is an approximation, experiments show excellent agreement with the true coalescent model with recombination, in terms of linkage disequilibrium (D') and allele frequency distributions (data not shown).
We simulated recombination at flat rate 10 -8 crossovers per basepair per meiosis, with no chiasma interference. Mutations were generated at rate 10 -8 per basepair per generation. The generated mutations constitute the set of all possible SNP markers and disease susceptibility loci for the study. The effective size of the population was 10,000 individuals.
In the second phase, inheritance of chromosomal segments in the founder population was simulated. We used the Populus simulator of Ollikainen for simulating random mating in distinct generations. [14] Recombinations were modeled as in the first phase; mutations were not simulated during the second phase. As a result, segment compositions of the individuals were obtained: for each individual, the two homologous chromosomes consisted of separate segments that have been inherited from the founder chromosomes intact.
The frequency for the disease susceptibility mutation and minimum minor allele frequency for markers were fixed for each study setting. For the choice of the disease susceptibility locus and marker map we therefore needed to compute the frequencies of the minor alleles. This was done for all SNPs in the final population by using the simulated chromosomal segment decompositions and the founder haplotypes acquired from the first phase simulation.
Next a set of approximately equidistantly spaced markers with a minor allele frequency exceeding a specified minimum frequency were chosen from the set of SNPs. At the same time, the disease susceptibility locus was chosen from the remaining SNPs such that the frequency of the disease susceptibility mutation was closest to the desired value. If there were more than one such candidates available, one of those was randomly chosen.
Individuals were diagnosed based on their genotype at the disease susceptibility locus and the specified disease model. After diagnosis, a desired sample was picked. Finally, allelic data was generated for the sampled individuals and their parents.
APPENDIX: HAPLOTYPING METHOD
For population-based statistical reconstruction of haplotypes we used the HaploRec algorithm, which is targeted especially for large numbers of relatively sparsely spaced markers. [6] HaploRec assumes Hardy-Weinberg equilibrium, which means that the probability of a haplotype pair is modeled as a product of the probabilities of the two individual haplotypes. The probability of a haplotype is broken into a product of conditional probabilities of individual alleles, with each allele conditional on a varying number of its immediate neighbors. When computing the probability of haplotype H of length l, the distribution of alleles at marker i is estimated by conditioning on the longest observed haplotype fragment that (1) matches haplotype H and ends at marker i -1, and (2) has an estimated relative frequency of at least 0.2%: ≥ 0.2%}. Using a frequency threshold is motivated by the fact that a long haplotype fragment is likely to be shared by several individuals only if it is inherited from the same ancestor, and thus is useful in estimating haplotypes.
Given parameter estimates for the variable-order Markov model, the haplotypes are reconstructed by choosing the phases such that the resulting pair of haplotypes has the maximal product of probabilities. As in practice neither the model parameters or the haplotypes are known in advance, the original HaploRec algorithm was adapted to apply an EM-like algorithm for simultaneously learning the model and reconstructing the haplotypes. The algorithm starts with an uniform model, and alternates between steps of reconstructing the haplotypes and estimating the model parameters.
